Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
GLP-1 receptor agonists like semaglutide and tirzepatide are temperature-sensitive medications that demand proper storage to maintain their potency and safety profile
Marketed by Vitruvias Therapeutics, this product is identified by NDC 69680-112 and is authorized under FDA application ANDA209255
Microdosing allows your body to adjust at its own pace rather than forcing it to adhere to a rigid manufacturers schedule that might be too aggressive for your biology
What This Means If You Are a Cost-Conscious GLP-1 User Right Now The biosimilar future is real, but it is not your present reality if you are in the United States
US$ 29.31
US$ 26.60
US$ 27.31
US$ 27.28
